CIK 0001119774 · Accelerated filer
COMPUGEN LTD
Sign in to watch- Ticker
- CGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 011-972-3-765-8585
- Business address
- 26 HAROKMIM STREET, BUILDING D, HOLON, Israel, 5885849
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- F-3 Offering F-3
- 6-K Event Report of Foreign Issuer
- 4 Planned sale SVP, Business Development sold 2,000 shares at $3.20 ($6,400)
- 4 Planned sale President and CEO sold 5,000 shares at $3.20 ($16,001)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale President and CEO sold 5,000 shares at $2.90 ($14,521)
- 4 Planned sale SVP, Business Development sold 2,000 shares at $2.80 ($5,600)
- 4/A Planned sale SVP, Business Development sold 3,125 shares at $2.56 ($8,013)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Business Development sold 3,125 shares at $2.56 ($8,013)
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Business Development sold 7,875 shares at an average $2.38 ($18,758)
- 4 Planned sale SVP, Business Development sold 3,500 shares at $2.20 ($7,700)
- 4 Planned sale President and CEO sold 5,625 shares at $2.21 ($12,413)
- 144 Insider Sale of Securities
Page 2 of 31 · 608 filings